CoChat
Sign Up
Cited by 364

MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response

Saba, Reuben, Sorensen, Debra L., Booth, Stephanie A.·2014·Frontiers in Immunology
DOI 10.3389/fimmu.2014.00578PMC PMC4240164
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2014.00578

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 84

  1. [4]Pasquinelli AE Reinhart BJ Slack F Martindale MQ Kuroda MI Maller B Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature (2000) 408(6808): 86– 9. 10.1038/35040556 11081512 · DOI
  2. [5]Ozsolak F Poling LL Wang Z Liu H Liu XS Roeder RG Chromatin structure analyses identify miRNA promoters. Genes Dev (2008) 22(22): 3172– 83. 10.1101/gad.1706508 19056895 PMC2593607 · DOI
  3. [6]Carthew RW Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell (2009) 136(4): 642– 55. 10.1016/j.cell.2009.01.035 19239886 PMC2675692 · DOI
  4. [7]Kim J Inoue K Ishii J Vanti WB Voronov SV Murchison E A MicroRNA feedback circuit in midbrain dopamine neurons. Science (2007) 317(5842): 1220– 4 10.1126/science.1140481 17761882 PMC2782470 · DOI · Paper page
  5. [9]Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell (2009) 136(2): 215– 33. 10.1016/j.cell.2009.01.002 19167326 PMC3794896 · DOI · Paper page
  6. [10]Brennecke J Stark A Russell RB Cohen SM. Principles of microRNA-target recognition. PLoS Biol (2005) 3(3): e85. 10.1371/journal.pbio.0030085 15723116 PMC1043860 · DOI
  7. [11]Lim LP Lau NC Garrett-Engele P Grimson A Schelter JM Castle J Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 433(7027): 769– 73. 10.1038/nature03315 15685193 · DOI · Paper page
  8. [13]Bartel DP Chen CZ Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet (2004) 5(5): 396– 400 10.1038/nrg1328 15143321 · DOI
  9. [14]Schratt G. Fine-tuning neural gene expression with microRNAs. Curr Opin Neurobiol (2009) 19(2): 213– 9. 10.1016/j.conb.2009.05.015 19539460 · DOI
  10. [15]Chen CZ Li L Lodish HF Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science (2004) 303(5654): 83– 6. 10.1126/science.1091903 14657504 · DOI · Paper page
  11. [16]Boldin MP Taganov KD Rao DS Yang L Zhao JL Kalwani M miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med (2011) 208(6): 1189– 201. 10.1084/jem.20101823 21555486 PMC3173243 · DOI · Paper page
  12. [17]Zhao JL Rao DS Boldin MP Taganov KD O’Connell RM Baltimore D. NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A (2011) 108(22): 9184– 9. 10.1073/pnas.1105398108 21576471 PMC3107319 · DOI · Paper page
  13. [18]Starczynowski DT Kuchenbauer F Argiropoulos B Sung S Morin R Muranyi A Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat Med (2010) 16(1): 49– 58 10.1038/nm.2054 19898489 · DOI
  14. [19]Lu LF Boldin MP Chaudhry A Lin LL Taganov KD Hanada T Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell (2010) 142(6): 914– 29. 10.1016/j.cell.2010.08.012 20850013 PMC3049116 · DOI
  15. [20]Akira S Uematsu S Takeuchi O Pathogen recognition and innate immunity. Cell (2006) 124(4): 783– 801 10.1016/j.cell.2006.02.015 16497588 · DOI
  16. [21]Slack JL Schooley K Bonnert TP Mitcham JL Qwarnstrom EE Sims JE Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inlammatory signaling pathways. J Biol Chem (2000) 275(7): 4670– 8. 10.1074/jbc.275.7.4670 10671496 · DOI
  17. [22]O’Neill LA Sheedy FJ McCoy CE. MicroRNAs: the fine-tuners of toll-like receptor signalling. Nat Rev Immunol (2011) 11(3): 163– 75. 10.1038/nri2957 21331081 · DOI
  18. [23]Takeuchi O Takeda K Hoshino K Adachi O Ogawa T Akira S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol (2000) 12(1): 113– 7. 10.1093/intimm/12.1.113 10607756 · DOI
  19. [24]Yamamoto M Sato S Hemmi H Hoshino K Kaisho T Sanjo H Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science (2003) 301(5633): 640– 3 10.1126/science.1087262 12855817 · DOI
  20. [25]Pauley KM Satoh M Chan AL Bubb MR Reeves WH Chan EK. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther (2008) 10(4): R101. 10.1186/ar2493 18759964 PMC2575615 · DOI
  21. [26]Nahid MA Pauley KM Satoh M Chan EK. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem (2009) 284(50): 34590– 9. 10.1074/jbc.M109.056317 19840932 PMC2787321 · DOI · Paper page
  22. [27]Hou J Wang P Lin L Liu X Ma F An H MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol (2009) 183(3): 2150– 8. 10.4049/jimmunol.0900707 19596990 · DOI · Paper page
  23. [28]Tang Y Luo X Cui H Ni X Yuan M Guo Y MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum (2009) 60(4): 1065– 75. 10.1002/art.24436 19333922 · DOI
  24. [29]Nahid MA Satoh M Chan EK. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol (2011) 186(3): 1723– 34. 10.4049/jimmunol.1002311 21178010 PMC3608687 · DOI
  25. [30]Williams AE Perry MM Moschos SA Larner-Svensson HM Lindsay MA. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans (2008) 36(Pt 6): 1211– 5. 10.1042/BST0361211 19021527 · DOI
  26. [31]El Gazzar M Church A Liu T McCall CE. MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming. J Leukoc Biol (2011) 90(3): 509– 19. 10.1189/jlb.0211074 21562054 PMC3157899 · DOI
  27. [32]Perry MM Moschos SA Williams AE Shepherd NJ Larner-Svensson HM Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol (2008) 180(8): 5689– 98. 10.4049/jimmunol.180.8.5689 18390754 PMC2639646 · DOI · Paper page
  28. [33]Perry MM Williams AE Tsitsiou E Larner-Svensson HM Lindsay MA. Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells. FEBS Lett (2009) 583(20): 3349– 55. 10.1016/j.febslet.2009.09.038 19786024 · DOI
  29. [34]Larner-Svensson HM Williams AE Tsitsiou E Perry MM Jiang X Chung KF Pharmacological studies of the mechanism and function of interleukin-1beta-induced miRNA-146a expression in primary human airway smooth muscle. Respir Res (2010) 11: 68– 9921–11–68. 10.1186/1465-9921-11-68 20525168 PMC2894768 · DOI
  30. [35]Jurkin J Schichl YM Koeffel R Bauer T Richter S Konradi S miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent activation. J Immunol (2010) 184(9): 4955– 65. 10.4049/jimmunol.0903021 20375304 · DOI
  31. [36]Karrich JJ Jachimowski LC Libouban M Iyer A Brandwijk K Taanman-Kueter EW MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells. Blood (2013) 122(17): 3001– 9. 10.1182/blood-2012-12-475087 24014244 PMC3811175 · DOI
  32. [37]Curtale G Mirolo M Renzi TA Rossato M Bazzoni F Locati M. Negative regulation of toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci U S A (2012) 110(28): 11499– 504. 10.1073/pnas.1219852110 23798430 PMC3710884 · DOI
  33. [38]Xiang M Birkbak NJ Vafaizadeh V Walker SR Yeh JE Liu S STAT3-regulated miR-146b forms a feedback circuit to counteract the NF-κB/IL-6 axis and STAT3-driven cancer phenotypes. Sci Signal (2014) 7(310): ra11. 10.1126/scisignal.2004497 24473196 PMC4233120 · DOI
  34. [39]Li Y Shi X. MicroRNAs in the regulation of TLR and RIG-I pathways. Cell Mol Immunol (2013) 10(1): 65– 71. 10.1038/cmi.2012.55 23262976 PMC4003181 · DOI
  35. [41]Chen XM Splinter PL O’Hara SP LaRusso NF. A cellular micro-RNA, let-7i, regulates toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem (2007) 282(39): 28929– 38. 10.1074/jbc.M702633200 17660297 PMC2194650 · DOI
  36. [42]Heikham R Shankar R. Flanking region sequence information to refine microRNA target predictions. J Biosci (2010) 35(1): 105– 18. 10.1007/s12038-010-0013-7 20413915 · DOI
  37. [43]Yang K He YS Wang XQ Lu L Chen QJ Liu J MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-lie receptor 4. FEBS Lett (2011) 585(6): 854– 60. 10.1016/j.febslet.2011.02.009 21329689 · DOI
  38. [44]He Y Sun X Huang C Long XR Lin X Zhang L MiR-146a regulates IL-6 production in lipopolysaccharide-induced RAW264.7 macrophage cells by inhibiting Notch1. Inflammation (2014) 37(1): 71– 82. 10.1007/s10753-013-9713-0 23974950 · DOI
  39. [45]O’Connell RM Rao DS Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol (2012) 30: 295– 312. 10.1146/annurev-immunol-020711-075013 22224773 · DOI
  40. [46]Bhaumik D Scott GK Schokrpur S Patil CK Orjalo AV Rodier F MicroRNAs miR146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (2009) 1(4): 402– 11. 20148189 PMC2818025
  41. [47]Jones SW Watkins G Le Good N Roberts S Murphy CL Brockbank SM The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage (2009) 17(4): 464– 72. 10.1016/j.joca.2008.09.012 19008124 · DOI
  42. [48]Cameron JE Yin Q Fewell C Lacey M McBride J Wang X Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol (2008) 82(4): 1946– 58. 18057241 PMC2258704
  43. [49]Motsch N Pfuhl T Mrazek J Barth S Grasser FA. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol (2007) 4(3): 131– 7. 10.4161/rna.4.3.5206 18347435 · DOI
  44. [50]Zhang Y Li Y. Regulation of innate receptor pathways by microRNAs. Sci China Life Sci (2013) 56(1): 13– 8. 10.1007/s11427-012-4428-2 23269554 · DOI
  45. [51]Kufer TA. Signal transduction pathways used by NLR-type innate immune receptors. Mol Biosyst (2008) 4(5): 380– 6. 10.1039/b718948f 18414735 · DOI
  46. [52]Proell M Riedl SJ Fritz JH Rojas AM Schwarzenbacher R. The nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One (2008) 3(4): e2119. 10.1371/journal.pone.0002119 18446235 PMC2323615 · DOI
  47. [53]Ghorpade DS Sinha AY Holla S Singh V Balaji KN. NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease. J Biol Chem (2013) 288(46): 33037– 48. 10.1074/jbc.M113.492496 24092752 PMC3829153 · DOI
  48. [54]Vyse TJ Kotzin BL Genetic basis of systemic lupus erythematosus. Curr Opin Immunol (1996) 8(6): 843– 51 10.1016/S0952-7915(96)80014-8 8994865 · DOI
  49. [55]Fairhurst AM Wandstrat AE Wakeland EK. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol (2006) 92: 1– 69. 10.1016/S0065-2776(06)92001-X 17145301 · DOI
  50. [56]Baechler EC Batliwalla FM Karypis G Gaffney PM Ortmann WA Espe KJ Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A (2003) 100(5): 2610– 5. 10.1073/pnas.0337679100 12604793 PMC151388 · DOI
  51. [57]Bennett L Palucka AK Arce E Cantrell V Borvak J Banchereau J Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med (2003) 197(6): 711– 23. 10.1084/jem.20021553 12642603 PMC2193846 · DOI
  52. [58]Kirou KA Lee C George S Louca K Papagiannis IG Peterson MG Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum (2004) 50(12): 3958– 67. 10.1002/art.20798 15593221 · DOI
  53. [59]Han GM Chen SL Shen N Ye S Bao CD Gu YY Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun (2003) 4(3): 177– 86 10.1038/sj.gene.6363966 12700592 · DOI
  54. [60]Luo X Yang W Ye DQ Cui H Zhang Y Hirankarn N A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet (2011) 7(6): e1002128. 10.1371/journal.pgen.1002128 21738483 PMC3128113 · DOI
  55. [61]Lofgren SE Frostegard J Truedsson L Pons-Estel BA D’Alfonso S Witte T Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun (2012) 13(3): 268– 74. 10.1038/gene.2011.84 22218224 PMC3640319 · DOI
  56. [62]Zhang J Yang B Ying B Li D Shi Y Song X Association of pre-microRNAs genetic variants with susceptibility in systemic lupus erythematosus. Mol Biol Rep (2011) 38(3): 1463– 8. 10.1007/s11033-010-0252-6 20845080 · DOI
  57. [63]Morgan AW Robinson JI Conaghan PG Martin SG Hensor EM Morgan MD Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort. Arthritis Res Ther (2010) 12(2): R57. 10.1186/ar2969 20353580 PMC2888207 · DOI
  58. [64]Nakasa T Miyaki S Okubo A Hashimoto M Nishida K Ochi M Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum (2008) 58(5): 1284– 92. 10.1002/art.23429 18438844 PMC2749927 · DOI
  59. [65]Stanczyk J Pedrioli DM Brentano F Sanchez-Pernaute O Kolling C Gay RE Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum (2008) 58(4): 1001– 9. 10.1002/art.23386 18383392 · DOI
  60. [66]Franzoso G Carlson L Xing L Poljak L Shores EW Brown KD Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev (1997) 11(24): 3482– 96. 10.1101/gad.11.24.3482 9407039 PMC316809 · DOI · Paper page
  61. [67]Clohisy JC Roy BC Biondo C Frazier E Willis D Teitelbaum SL Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis. J Immunol (2003) 171(10): 5547– 53. 10.4049/jimmunol.171.10.5547 14607962 · DOI
  62. [68]Yang B Zhang JL Shi YY Li DD Chen J Huang ZC Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population. Mol Biol Rep (2011) 38(8): 4913– 9 10.1007/s11033-010-0633-x 21181275 · DOI
  63. [69]Chatzikyriakidou A Voulgari PV Georgiou I Drosos AA. A polymorphism in the 3’-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine (2010) 77(5): 411– 3. 10.1016/j.jbspin.2010.05.013 20870441 · DOI
  64. [70]Chatzikyriakidou A Voulgari PV Georgiou I Drosos AA. The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol (2010) 71(5): 382– 5. 10.1111/j.1365-3083.2010.02381.x 20500689 · DOI
  65. [71]Pauley KM Stewart CM Gauna AE Dupre LC Kuklani R Chan AL Altered miR-146a expression in Sjogren’s syndrome and its functional role in innate immunity. Eur J Immunol (2011) 41(7): 2029– 39. 10.1002/eji.201040757 21469088 PMC3760391 · DOI · Paper page
  66. [72]Zilahi E Tarr T Papp G Griger Z Sipka S Zeher M. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjogren’s syndrome. Immunol Lett (2012) 141(2): 165– 8. 10.1016/j.imlet.2011.09.006 22033216 · DOI
  67. [73]Bombardieri M Barone F Pittoni V Alessandri C Conigliaro P Blades MC Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren’s syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther (2004) 6(5): R447– 56 10.1186/ar1209 15380044 PMC546280 · DOI
  68. [74]Eriksson P Andersson C Ekerfelt C Ernerudh J Skogh T. Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjogren’s syndrome, rheumatoid arthritis and healthy controls. Clin Exp Immunol (2004) 137(3): 617– 20. 10.1111/j.1365-2249.2004.02562.x 15320916 PMC1809152 · DOI
  69. [75]Szodoray P Alex P Brun JG Centola M Jonsson R. Circulating cytokines in primary Sjogren’s syndrome determined by a multiplex cytokine array system. Scand J Immunol (2004) 59(6): 592– 9. 10.1111/j.0300-9475.2004.01432.x 15182255 · DOI · Paper page
  70. [76]Yamano S Atkinson JC Baum BJ Fox PC. Salivary gland cytokine expression in NOD and normal BALB/c mice. Clin Immunol (1999) 92(3): 265– 75. 10.1006/clim.1999.4759 10479531 · DOI
  71. [77]Kiko T Nakagawa K Tsuduki T Furukawa K Arai H Miyazawa T. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer’s disease. J Alzheimers Dis (2014) 39(2): 253– 9. 10.3233/JAD-130932 24157723 · DOI · Paper page
  72. [78]Muller M Kuiperji HB Claassen JA Kusters B Verbeek MM. MicroRNAs in Alzheimers disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging (2014) 35(1): 152– 8. 10.1016/j.neurobiolaging.2013.07.005 23962497 · DOI
  73. [79]Lukiw WJ Dua P Pogue AI Eicken C Hill JM. Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J Toxicol Environ Health A (2011) 74(22–24): 1460– 8. 10.1080/15287394.2011.618973 22043907 PMC3719866 · DOI
  74. [80]Ma X Zhou J Zhong Y Jiang L Mu P Li Y Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci (2014) 11(8): 810– 8. 10.7150/ijms.8647 24936144 PMC4057480 · DOI
  75. [81]Lukiw WJ Zhao Y Cui JG. An NF-kappaB-sensitive micro RNA- 146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem (2008) 283(46): 31315– 22. 10.1074/jbc.M805371200 18801740 PMC2581572 · DOI · Paper page
  76. [82]Lukiw WJ Alexandrov PN. Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimers disease (AD) brain. Mol Neurobiol (2012) 46(1): 11– 9. 10.1007/s12035-012-8234-4 22302353 PMC3703615 · DOI
  77. [83]Li YY Cui JG Dua P Pogue AI Bhattacharjee S Lukiw WJ. Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci Lett (2011) 499(2): 109– 13. 10.1016/j.neulet.2011.05.044 21640790 PMC3713470 · DOI
  78. [84]Saba R Goodman CD Huzarewich RL Robertson C Booth SA. A miRNA signature of prion induced neurodegeneration. PLoS One (2008) 3(11): e3652. 10.1371/journal.pone.0003652 18987751 PMC2575400 · DOI · Paper page
  79. [85]Majer A Medina SJ Niu Y Abrenica B Manguiat KJ Frost KL Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog (2012) 8(11): e1003002 10.1371/journal.ppat.1003002 23144617 PMC3493483 · DOI
  80. [87]Williams A Lucassen PJ Ritchie D Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol (1997) 144: 433– 8. 10.1006/exnr.1997.6424 9168844 · DOI · Paper page
  81. [88]Jiang M Xiang Y Wang D Gao J Liu D Liu Y Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell (2012) 11(1): 29– 40. 10.1111/j.1474-9726.2011.00757.x 21981419 · DOI
  82. [89]Caldeira C Oliveria AF Cunha C Vaz AR Falcao AS Fernandes A Microglia change from a reactive to an age-like phenotype with the time in culture. Front Cell Neurosci (2014) 8: 152. 10.3389/fncel.2014.00152 24917789 PMC4040822 · DOI · Paper page
  83. [90]Ferraccioli G Carbonella A Gremese E Alivernini S. Rheumatoid arthritis and Alzheimers disease: genetic and epigenetic links in inflammatory regulation. Discov Med (2012) 14(79): 379– 88. 23272690
  84. [91]Eikelenboom P Bate C Van Gool WA Hoozemans JJ Rozemuller JM Veerhuis R Neuroinflammation in Alzheimer’s disease and prion disease. Glia (2002) 40(2): 232– 9. 10.1002/glia.10146 12379910 · DOI

Cited by

Sorted by citations

Authors
Saba, R., Sorensen, D. L., & Booth, S. A.
Venue
Frontiers in Immunology
Publisher
Frontiers Media SA
Published
2014-11-21
Volume
5
ISSN
1664-3224
DOI
10.3389/fimmu.2014.00578
PMC
PMC4240164
Cited by
364
References
7

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review